Published in Surgery on May 01, 1985
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet (1990) 1.25
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet (1989) 0.92
Surgical complications in human orthotopic liver transplantation. Acta Chir Belg (1987) 0.85
How do we manage post-OLT redundant bile duct? World J Gastroenterol (2013) 0.76
Interventional radiology: management of biliary complications of liver transplantation. Semin Intervent Radiol (2004) 0.75
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin Exp Immunol (1982) 2.00
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut (2001) 1.86
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg (2001) 1.72
A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71
Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol (1994) 1.69
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68
Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation (1987) 1.65
Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis (1991) 1.59
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc (1994) 1.59
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53
Analysis of survival and morbidity after pediatric liver transplantation with full-size and technical-variant grafts. Transplantation (1999) 1.52
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl (2001) 1.48
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
A rapid method for blood ammonia determination using the new blood ammonia checker (BAC) II. Clin Chim Acta (1992) 1.45
[Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]. Ned Tijdschr Geneeskd (2002) 1.45
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43
Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation (2001) 1.42
The contribution of various organs to ammonia formation: a review of factors determining the arterial ammonia concentration. Ann Clin Biochem (1996) 1.42
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J Infect Dis (1998) 1.42
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology (1993) 1.41
Noninvasive metabolic assessment of human donor livers: prognostic value of 31P-magnetic resonance spectroscopy for early graft function. Transplantation (1997) 1.40
The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg (1994) 1.40
[Good results with liver resection for colorectal liver metastases]. Ned Tijdschr Geneeskd (1995) 1.40
Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30
Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant (2006) 1.26
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26
Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation (2001) 1.25
Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation (1996) 1.22
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology (1994) 1.21
Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis (1989) 1.19
The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology (1987) 1.19
Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology (1993) 1.18
FK506-induced neurotoxicity in liver transplantation. Ann Neurol (1994) 1.16
Outcome of the use of pediatric donor livers in adult recipients. Liver Transpl (2001) 1.14
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection. Hepatology (1994) 1.14
Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology (1997) 1.14
Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14
Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology (2001) 1.13
Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc (1997) 1.12
Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11
Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology (1991) 1.11
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology (1998) 1.11
Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology (1991) 1.10
The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl (1999) 1.10
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation (1988) 1.10
Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc (1991) 1.10
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology (1998) 1.09
Surgical treatment of giant haemangioma of the liver. Br J Surg (1997) 1.09
Choledochocholedochostomy is successful in orthotopic liver transplantation. Transplant Proc (1984) 1.09
Splenic artery aneurysms in liver transplant patients. Transplantation (1988) 1.08
[Liver transplantation: patients' experiences]. Ned Tijdschr Geneeskd (1989) 1.08
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology (1992) 1.08
Delayed immune hemolysis in a patient receiving cyclosporine after orthotopic liver transplantation. Transfusion (1988) 1.07
Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation (1988) 1.06
Ochrobactrum intermedium infection after liver transplantation. J Clin Microbiol (1999) 1.06
Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. Transplantation (1990) 1.04
Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol (1997) 1.04
Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation (1998) 1.04
Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture. Hepatology (1996) 1.03
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation (1993) 1.03
Colon perforation after kidney transplantation. Ann Surg (1978) 1.03
Histopathology of serial graft biopsies from liver transplant recipients. Am J Pathol (1984) 1.03
Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology (1992) 1.03
Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Clin Exp Immunol (1984) 1.03
Guillain-Barré syndrome in acute HBs Ag-positive hepatitis. Br Med J (1975) 1.03
Percutaneous drainage of emphysematous cholecystitis associated with pneumoperitoneum. Hepatogastroenterology (1999) 1.03
Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation (1996) 1.02
Ultrasound and cholangiography for the diagnosis of biliary complications after orthotopic liver transplantation: a comparative study. J Clin Ultrasound (1996) 1.02
Selection criteria and decisions in 375 patients with liver disease, considered for liver transplantation during 1977-1985. Liver (1987) 1.01
Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology (1991) 1.01
Early magnetic resonance imaging compared with bone scintigraphy in suspected scaphoid fractures. J Bone Joint Surg Br (2008) 1.00
Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. Mayo Clin Proc (1993) 0.99
Determination of ammonia in biological fluids. Ann Clin Biochem (1994) 0.99
Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg (1997) 0.99
Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology (1995) 0.99
IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. A longitudinal study over 5 years. Acta Hepatogastroenterol (Stuttg) (1978) 0.98
Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol (1988) 0.98
Splenic artery aneurysms in liver transplant patients. Liver Transplant Group. J Hepatol (1997) 0.98
Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc (1994) 0.97